REACH Awards 2019 - Honoring game-changers you work with
Here is an exciting opportunity to showcase the groundbreaking research, advocacy and frontline health provision that is taking place at the South African Medical Research Council and in your networks.
The 2019 REACH Awards will be recognizing stories of unsung achievement in disease elimination (Malaria, Tuberculosis, NTDs, and more) and raise awareness of the role of game-changing innovators within the larger global health community. Prominent leaders from across global health disciplines will judge the awards, including:
· Professor Baron Peter Piot, Director of the London School of Hygiene & Tropical Medicine
· Dr. Chris Elias, President of Global Development Division, Bill & Melinda Gates Foundation
· Dr. Maha Barakat, Executive Chair of the Roll Back Malaria Partnership
The winners will receive an undisclosed monetary prize, media visibility and the opportunity to come to Abu Dhabi’s Reaching the Last Mile Forum in November to receive the awards in front of high level global health leaders such as Bill Gates and Dr. Tedros.
About the 2019 REACH Awards
The REACH Awards uniquely honor unsung heroes working in the field of disease elimination who have demonstrated extraordinary leadership and commitment. Categories include:
· The Unsung Hero Award honors an extraordinary individual who has played a transformative, frontline role in the field of disease elimination, and has been under-recognized for his or her efforts.
· The Game-changing Innovator Award recognizes an individual who has developed and implemented a creative technology or practice in support of disease elimination.
· The Rising Champion Award celebrates an individual who is championing a cause related to disease elimination.
Nominations will remain open until July 12.
The Awards will be presented at the biennial Reaching the Last Mile Forum in November in front government officials, bilateral and multilateral aid leaders, global health experts, and industry leaders.
Articles
Virtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
- elucidate the mechanisms by
which the immune system recognizes the Mtb-infected cell
- explore the degree to which
such recognition can lead to control of the intracellular microbe, and
- discuss the translational
implications of these observations
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
Ethical Review Of Decentralized Clinical Trials (Dcts): Tools, Resources & Best Practices.
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here